论文部分内容阅读
目的探讨疏血通注射液治疗急性脑梗死的临床疗效。方法选取我院2015年1月—2015年9月收治的急性脑梗死病人84例,随机分两组,每组42例。对照组应用维脑路通注射液400mL加入生理盐水250mL或5%葡萄糖注射液250mL中静脉输注,每日1次,共14d。治疗组应用疏血通注射液6mL加入生理盐水250mL或5%葡萄糖注射液250mL静脉输注,1次/日,共14d。治疗前后进行神经功能缺损评分。结果治疗组总有效率达95.2%,对照组73.8%,差异有统计学意义(P<0.05)。结论疏血通注射液治疗急性脑梗死安全有效。
Objective To investigate the clinical effect of Shuxuetong injection in the treatment of acute cerebral infarction. Methods Eighty-four patients with acute cerebral infarction who were admitted to our hospital from January 2015 to September 2015 were randomly divided into two groups (n = 42 in each group). In the control group, 400 mL of Weitailu injection was added to 250 mL of medium of normal saline 250 mL or 5% dextrose injection of intravenous infusion once daily for 14 days. Treatment group, Shuxuetong injection 6mL added saline 250mL or 5% glucose injection 250mL intravenous infusion, 1 time / day, a total of 14d. Before and after treatment for neurological deficit score. Results The total effective rate was 95.2% in the treatment group and 73.8% in the control group, the difference was statistically significant (P <0.05). Conclusion Shuxuetong injection in the treatment of acute cerebral infarction safe and effective.